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Abstract Paroxysmal dyskinesia (PxD) is a group of
movement disorders characterized by recurrent episodes of
involuntary movements. Familial paroxysmal kinesigenic
dyskinesia (PKD) is caused by PRRT2 mutations, but a
distinct etiology has been suggested for sporadic PKD.
Here we describe a cohort of patients collected from our
movement disorders outpatient clinic in the period
1996–2011. Fifteen patients with sporadic PxD and 23
subjects from three pedigrees with familial PKD were
screened for mutations in candidate genes. PRRT2 muta-
tions co-segregated with PKD in two families and occurred
in two sporadic cases of PKD. No mutations were detected
in patients with non-kinesigenic or exertion-induced dys-
kinesia, and none in other candidate genes including
PNKD1 (MR-1) and SLC2A1 (GLUT1). Thus, PRRT2
mutations also cause sporadic PKD as might be expected
given the variable expressivity and reduced penetrance
observed in familial PKD. Further genetic heterogeneity is
suggested by the absence of candidate gene mutations in
both sporadic and familial PKD suggesting a contribution
of other genes or non-coding regions.
Keywords Paroxysmal kinesigenic dyskinesia  Infantile
convulsions and paroxysmal choreoathetosis  Benign
familial neonatal convulsions  Migraine
Introduction
Paroxysmal dyskinesias (PxDs) are characterized by
recurrent episodes of abnormal involuntary movements [1].
The movement disorder may clinically present as dystonia,
chorea, ballism or a mixture of these [2]. Attacks often
begin in childhood [3]. A classification scheme distin-
guishes four subtypes: paroxysmal kinesigenic (PKD),
non-kinesigenic (PNKD), exertion-induced (PED) and
hypnogenic dyskinesia (PND) [2].
In PKD, the most frequent form, attacks are precipitated by
voluntary movements and usually last less than 5 min [4].
Familial PKD inherits in an autosomal dominant mode with
reduced penetrance [3]. Infantile convulsions (IC) were fre-
quently observed in the same pedigree and PKD and ICCA (IC
with choreoathetosis) are now considered the same disorder
[5–9]. Recently, the PRRT2 gene was shown to cause familial
PKD [10–16]. A quarter of PKD cases are sporadic. Several
observations suggested that sporadic and familial forms may
be etiologically distinct, featuring a higher number of attacks
per day and an increased co-occurrence of migraine in spo-
radic patients (full reference list in Online Resource 1).
In PNKD attacks are triggered by alcohol, caffeine, fati-
gue or excitement [2]. Attacks typically last minutes to 4 h.
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Mutations in the MR-1 gene have been detected in several
families [17, 18]. Clonazepam or other benzodiazepines can
be helpful in some MR-1 mutation carrier patients [19].
PED is triggered by prolonged physical exercise [20].
The symptom duration varies from 5–30 min [1, 3]. Few
families have been described [21–24] as well as some
sporadic patients [25, 26]. In some families epilepsy or
migraine co-occur. In nine families with PED and epilepsy,
mutations were found in the SLC2A1 gene encoding the
glucose transporter GLUT1 [27, 28].
Here we investigated a cohort of 33 Dutch PxD patients
and found PRRT2 frameshift mutations in both familial and
sporadic cases of PKD. Furthermore, the majority of spo-
radic PxD cases as well as one PKD family did not carry
mutations in PRRT2, MR-1 or GLUT1, suggesting a con-
tribution of additional genes or non-coding mutations.
Subjects and methods
This study was performed in accordance with the ethical
standards laid down in the 1964 declaration of Helsinki and
was approved by the Institutional Review Board of the VU
Medical Center (#2009/174). Informed written consent was
obtained from all participating subjects. All patients with PxD
in the Academic Medical Center (AMC), diagnosed between
1996 and 2010 were asked to participate. All participants
completed a standardised questionnaire including age at
onset, frequency, duration, triggers, symptoms during attacks,
precipitating and alleviating factors, symptoms after an attack
and family and medical history. Medical records EEG (elec-
tro-encephalogram, if achieved) and imaging reports were
reviewed. In PKD families some unaffected family members
were also examined. For genetic analysis, we collected
venous blood samples (adults) or sputum (children). Genomic
DNA was isolated using the PureGene Blood core kit
(Qiagen). For familial cases, co-seggregation of the pheno-
type with chromosome 16 was confirmed using 23 micro-
satellite repeats (see Online Resource 2). PCR amplification
of target genes was performed using primers specified in
Online Resource 3. Products were sequenced using BigDye-
Terminator v3.1 reagents and analyzed in a ABI Prism 3137
genetic analyzer. All patients were tested for PRRT2. Patients
with PKD or PED were also tested for mutations in GLUT1.
PNKD patients were also tested for MR-1 gene mutations.
Results
Patients
Thirty-three PxD patients were detected and 23 volun-
teered to participate. Sixteen patients met the criteria for
PKD including seven patients with a positive family his-
tory (Table 1). The average age at onset was 14.1 years
(ranging from 0 to 51) and did not differ significantly
between familial and sporadic cases (12.4 and 15.4 years,
respectively). There is a male predominance (63 %).
Dystonia was observed in 88 % of the patients, whereas
31 % exhibited chorea. Combined dystonia and chorea was
observed in 25 % of the patients. Seven patients tried
carbamazepine and all experienced good control of com-
plaints. Accompanying ailments were IC, epilepsy,
migraine and tremor. It should be noted that IC were only
present in the familial group.
The first family of Indonesian descent (Fig. 1) contains
two patients with PKD, one with IC and one with migraine.
The index patient (II-2), a 37-year-old woman, reported
attacks of 10 s or less since the age of 12 years. Attacks
consisted of a right-sided dystonic posture of her neck, jaw,
hand, arm and leg. She experienced a preceding sensation
and could abort attacks, the frequency of which decreased
without medication. Her younger brother (III-3) had an
identical phenotype. His attacks stopped with carbamaze-
pine (50 mg per 2 days). Her daughter (IV-2) had IC
without EEG abnormalities at the age of 6 months. In the
past her mother (I-2) had migraine.
The second family consists of three PKD patients of
Dutch origin. The index patient (IV-2), a 13-year-old boy had
paroxysms since the age of 10 years after switching from rest
to action. The attacks consisted of dystonic posture of his left
arm followed by his mouth and leg. He had tremors of the
hands and sudden involuntary movement of his neck. The
patient experienced a preceding sensation and could abort an
attack. The attacks presented less than five times a day, lasted
10–15 s and ceased with carbamazepine (50 mg dd). His
mother (III-1) experienced similar attacks in her youth
(10–20 years). She also reported a febrile convulsion at
1 year of age. The grandfather (II-4) had similar attacks
when he was young and also exhibited tremors of the hands.
A great-uncle (II-1) also experienced involuntary move-
ments, but specifics were not possible to collect. The older
brother (IV-1) had a febrile convulsion at 1 year of age.
The third family includes two PKD patients. The index
patient (III-1) had PKD since age 15 years. The attack con-
sisted of left-sided slow kicking movements causing him to
fall. Occasionally a sensory warning preceded the attack, but
he was unable to prevent attacks. They stopped with car-
bamazepine (2 dd 200 mg). He was previously diagnosed
with benign familial infantile convulsions (BFIC) treated
with valproic acid, and had a single generalized tonic–clonic
seizure at age 13 years and twice again at age 14 years.
Interictal EEG showed series of epileptic discharges over the
right frontocentral area, especially during drowsiness and
hyperventilation [29]. Considering the PKD and seizures, the
diagnosis ICCA was made.
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Besides PKD patients, our cohort contained four spo-
radic PNKD patients and one female PED patient. The
average onset age of PNKD was 4.75 (0–10) years similar
to previous findings [1, 26, 30]. Again, dystonia was the
most common expression. Two patients tried carbamaze-
pine without effect. Two patients had migraine. The female
PED patient had isolated dystonia. Complaints started at
age 16 years; attacks gradually decreased and she had her
last attack at age 23 years. During an attack she took clo-
bazam to stop the complaints. It is common to have no
family history for PED [26].
Several patients underwent a brain CT-scan or MRI
(Table 1). All were normal. Only in the PED patient three
small lacunar lesions appeared in the right sided basal
ganglia, especially the global pallidus and adjacent to the
internal capsule. In EEG registrations, most of the patients
showed no epileptic discharges. Clinical epilepsy was
confirmed by neurophysiological investigation in only one
PKD patient (III-1 of family 3) (Table 1). In a patient with
PNKD and mental retardation an EEG showed indications
for epilepsy, but clinically no convulsions ever occurred.
Mutation detection
For familial PKD, PRRT2 mutations have been observed in
multiple Han Chinese families [10–13, 16, 31]. Consis-
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(c.649dupC) and 3 (c.649C[T, introducing an opal stop
codon replacing proline 217). In family 2 we did not find
any mutation, although the phenotype co-seggregated with
a region of chromosome 16p distal from marker D16S685
(see Online Resource 2).
In addition, two sporadic PKD patients carried frame-
shift mutations in PRRT2 (Table 1; Fig. 2) c.649delC
(patient 4) and c.649dupC (patient 6). Another variation,
c.3698T[C, was observed in the 30UTR in exon 4.
Although this variation is not reported in dbSNP or the
1,000 genome database it is not predicted to have major
effects on PRRT2 gene function.
Six out of nine cases of sporadic PKD were not asso-
ciated with mutations in PRRT2. We also did not detect
mutations in other candidate genes tested including MR-1
(known to cause PNKD) and GLUT1 (known to cause PED
and sporadic PKD) [32].
Discussion
We investigated the clinical and genetic aspects of 21 PxD
patients seen over the last 15 years in our third opinion
movement disorder out-patient clinic. This cohort com-
prised 16 patients with PKD, four with PNKD and one with
PED. Familial PKD co-seggregated with the known locus
in all pedigrees. PRRT2 truncating mutations were identi-
fied in two families and two sporadic cases.
In our study 53 % of the PKD patients were sporadic
cases, whereas only 4.8 % of published cases were spo-
radic [4, 33]. Possibly sporadic forms are underrepresented,
because linkage and gene identification studies preferen-
tially focussed on familial forms. Other clinical aspects of
patients in our cohort were similar to those of in total 681
published PKD patients (see Online Resource 1). The mean
age at onset was similar (10.4 years on average) and as in
our cohort, dystonia was also the most common movement
disorder in literature (seen in 43 % of patients). Both in
literature (30 %) and in our findings PKD and IC are cor-
related, especially in the familial forms [9].
The clinical features of sporadic and familial PKD
patients were similar, although IC were observed only in
the familial group. Migraine occurred in two of nine spo-
radic PKD cases and in one PRRT2 mutation carrier in
family 1 (I-2). The attacks were preceded by an aura in
93 % of sporadic patients and in all adult familial patients
questioned.
Despite the previous idea that sporadic and familial
PKD represent distinct diseases, we observed identical
mutations in sporadic and familial PKD [11–13]. This is
consistent with a recent study [16]. A pseudo-sporadic
occurrence is not surprising in view of the reduced pene-
trance of familial PKD combined with the variable clinical
expression that includes IC, BFIC and migraine [14, 15].
The lack of PRRT2 mutations in four out of seven
sporadic cases from our cohort suggests that additional
PKD genes exist. In another recent study, seven out of
eight sporadic cases were negative for PRRT2 mutations
[16]. Similarly, familial PKD cases occur without PRRT2
mutations both in our study and previous investigations
[16]. This suggests a contribution of other genes which
may co-segregate with the same locus as PRRT2 or alter-
natively of non-coding mutations that may affect PRRT2
gene function.
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